MTATP6P3

Across TCGA pan-cancer cohorts, MTATP6P3 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of MTATP6P3’s most consistent transcriptional readouts.

The strongest signal is observed in kidney chromophobe (KICH), where MTATP6P3 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MTATP6P3 is over-expressed in tumor, although a few such as PAAD show the opposite, repressed pattern.

KICH, COAD, and PAAD are the cancer types where MTATP6P3 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MTATP6P3 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KICH	All	All	+0.600	.002	3	view →
COAD	Female	III,IV	+0.164	.040	3	view →
PAAD	Female	All	−0.195	.005	2	view →
HNSC	Female	II,III,IV	+0.035	.038	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

MTATP6P3–KICH

Open the KICH breakdown →